Winrevair Archives - PHAEUROPE & Global

EMA Approves WINREVAIR (Sotatercept) for Treatment of PAH

August 27, 2024

PHA Europe is pleased to share the exciting news that the European Medicines Agency (EMA) has approved WINREVAIR™ (sotatercept) for the treatment of Pulmonary Arterial

Sotatercept approved by FDA

March 27, 2024

Merck, also known as MSD outside of the United States and Canada, has announced the FDA approval of Winrevair™ (sotatercept), a groundbreaking biologic for the

Winrevair

EMA Approves WINREVAIR (Sotatercept) for Treatment of PAH

Sotatercept approved by FDA

High-Level Forum on Lung Health

Lucilla Piccari, MD, PhD

Crown Princess Mette-Marit and lung fibrosis: raising awareness of serious lung disease